Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 64 publications
Inflammation as a therapeutic target to improve kidney and cardiovascular outcomes.
Journal: Nature reviews. Nephrology
Published: August 06, 2026
Nirmatrelvir-ritonavir targeting viral persistence in post-COVID-19 condition (long COVID) in the USA (RECOVER-VITAL): a randomised, double-blind, placebo-controlled, phase 2 trial.
Journal: The Lancet. Infectious diseases
Published: April 05, 2026
Risks of Major Adverse Kidney Events in Non-Hispanic Black Patients with Diabetes or Hypertension: A real-world cohort study.
Journal: American journal of nephrology
Published: March 18, 2026
Major Adverse Kidney Events in the American Indian or Alaska Native Population with Diabetes.
Journal: Clinical journal of the American Society of Nephrology : CJASN
Published: January 27, 2026
A Systematic Literature Review of Coordinated Care in Cardiovascular-Kidney-Metabolic Conditions.
Journal: Mayo Clinic proceedings. Innovations, quality & outcomes
Published: December 01, 2025
Therapeutic Considerations in Preventing Chronic Kidney Disease.
Journal: Annual review of medicine
Published: November 21, 2025
GLP-1 receptor agonists and next-generation metabolic hormone therapies in chronic kidney disease.
Journal: Nature reviews. Nephrology
Published: November 13, 2025
A Scoping Review of Pharmacist-Based Interprofessional Interventions for Management of Cardiovascular-Kidney-Metabolic Conditions.
Journal: Journal of the American College of Clinical Pharmacy : JACCP
Published: October 19, 2025
Cardiovascular-Kidney-Metabolic Syndrome: Rethinking Risk, Redefining Care.
Journal: Heart, lung & circulation
Published: October 08, 2025
Social Determinants of Health and Risk for Long COVID in the U.S. RECOVER-Adult Cohort.
Journal: Annals of internal medicine
Published: July 28, 2025
Role of Glucagon-Like Peptide-1 and Glucose-Dependent Insulinotropic Polypeptide/Glucagon-Like Peptide-1 Receptor Agonists in Management of Cardiovascular-Kidney-Metabolic (CKM) Conditions.
Journal: Cardiology clinics
Published: June 29, 2025
Population Risk Predictors of Major Adverse Kidney Events in Patients with Focal Segmental Glomerulosclerosis from the CURE-CKD Registry.
Journal: Research square
Published: May 19, 2025
Last Updated: 09/26/2026